1 December is World’s AIDS day. A day to recognise and address the ongoing disparities related to Human Immunodeficiency Virus (HIV) and acquired immunodeficiency syndrome (AIDS). This year the World Health Organization (WHO) has partnered with World AIDS day to highlight the inequalities that are restricting ending the HIV pandemic. This global health day aims to equalise vital HIV services to the most at-risk populations and destigmatize HIV/AIDs through education. According to UNAIDS, in 2021, there were 38.4 million people globally living with HIV and 1.5 million were newly infected. In GlobalData’s HIV tests market model indicates that more than 538 million HIV tests were sold globally in 2021 and almost 540 million will be sold in 2030*. GlobalData predicts that the global HIV test market will reach $2.3bn by 2030* growing at a CAGR of 1.5%.
The Covid-19 pandemic normalised frequent disease testing. People are becoming more proactive in monitoring their health, particularly in infectious diseases. This testing momentum coupled with increased HIV awareness and education will push people to get tested more frequently. According to GlobalData’s analysis, the HIV test market has recovered from the decreased market revenue observed in 2020 due to the Covid-19 pandemic as many health organisations such as the CDC, decreased public spending on HIV testing to compensate for Covid-19 testing.
*Not including multi-parameter HIV, Hepatitis B, and Hepatitis C Nucleic Acid Amplification Tests